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1. Introduction 
This work was designed to test the possibility that 
in vivo the rat corpus luteum might depend upon access 
to a specific plasma lipoprotein for its ability to synthe- 
size progesterone in response to lutropin. Previous 
work relevant to this question has yielded inconclusive 
evidence. For example, in rats treated [1] with 4-APP 
to lower their plasma lipoprotein levels [2], plasma 
progesterone levels fell below normal but were restored 
after infusing HDL into the circulation for 42 h. 
However, changes in plasma progesterone levels do 
not necessarily indicate changes in the rate of luteal 
progesterone synthesis. Furthermore, the infused HDL 
need not have been acting directly upon the corpus 
luteum and indeed might have undergone metabolic 
modification, either in the plasma [3] or following 
uptake by the liver [4], during the long period of 
infusion. A lower rate of progesterone synthesis was 
observed [5] in luteal cells isolated from rats treated 
with 4-APP than in similar cells isolated from 
untreated rats, but this observation alone gives no 
significant information regarding the role of lipopro- 
teins in luteal progesterone synthesis. Clearly instead 
of affecting progesterone synthesis ndirectly, through 
its effect on plasma lipoprotein levels, the 4-APP could 
have been acting directly on the corpus luteum in 
such a way as to damage the mechanism of progester- 
one synthesis. Without evidence on this latter possi- 
bility the observed effect of 4-APP on progesterone 
synthesis cannot be interpreted unequivocally, but no 
convincing evidence was presented [5]. Such evidence 
is, however, described below. We have shown that the 
low rate of lutropin-dependent progesterone synthesis 
in luteal cells from 4-APP-treated rats was restored to 
within the normal range by providing the isolated 
cells with rat plasma total lipoprotein fraction, and 
that of the main species of rat plasma lipoproteins, 
only HDL was able to enhance progesterone synthesis. 
2. Materials and methods 
Sources of animals and chemicals were as listed in 
[6]. Methods for superovulating rats, treating them 
with 4-APP, preparing and incubating isolated luteal 
cells and assaying progesterone were as in [6]. Rat 
serum total lipoprotein fraction (d < 1.225) was 
prepared as in [7] and dialysed for 48 h against four 
1 litre volumes of 0.15 M NaC1 before use. Separated 
rat plasma lipoproteins, prepared as in [8] were kindly 
provided by Dr E. R. Skinner, Department of Bio- 
chemistry, Marischal College, University of Aberdeen. 
Cholesterol and cholesteryl ester were extracted from 
cell suspensions, isolated by TLC and estimated by 
procedures used for sterol analysis of microsomal 
suspensions [9]. 
3. Results and discussion 
Abbreviations: 4-APP, 4-aminopyrazolo 3, 4-d pyrimidine; 
HDL, high-density lipoprotein (d = 1.065-1.209); LDL, low- 
density lipoprotein (d = 1.006-1.065); VLDL, very low- 
density lipoprotein (d < 1.006); TLC, thin-layer chromatog- 
raphy 
The rate oflutropin-dependent progesterone syn- 
thesis by luteal cells isolated from 4-APP-treated rats 
was linear for up to 2 h incubation time, but there- 
after slowed to a plateau after 4 -5  h (not shown); 
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Fig. 1. Effect of plasma total ipoprotein fraction on proges- 
terone synthesis by isolated luteal cells. Conditions were as in 
table 1 except hat the amount of plasma total ipoprotein 
fraction added to each incubation was varied as shown in the 
graphs; lutropin (100 ng/ml) was present in all incubations: 
(A) obtained using luteal cells from 4-APP-treated rats; 
(B) using cells from rats not treated with 4-APP. Each point 
on the graph is the mean ± SEM of 3 (A) or 5 (B) separate 
determinations on separate batches of cells. 
this rate was also ~ l /8 th  of that given by cells from 
rats not treated with 4-APP (table 1A). Fig.lA shows 
however that the rate of progesterone synthesis by 
these cells was enhanced 9-fold, to values within the 
range of rates given by cells isolated from rats not 
treated with 4-APP, by the total lipoprotein fraction 
of  rat plasma. Increasing the concentration of this 
lipoprotein fraction beyond that shown in fig. 1A was 
found to give no further enhancement of progester- 
one synthesis (not shown). In contrast, progesterone 
synthesii by cells isolated from rats not treated with 
4-APP was not significantly affected (P > 0.05) by 
plasma lipoproteins (fig. 1B); evidently the steroido- 
genic response to lipoproteins by cells isolated from 
4-APP-treated rats (fig.lA) is a consequence of the 
4-APP treatment, and is no{ a general property shared 
with cells from untreated rats. Plasma lipoproteins 
had no effect on progesterone synthesis unless lutro- 
pin was present (table 1B), demonstrating that the 
lipoproteins themselves do not stimulate progester- 
one synthesis, but rather enable the cells to respond 
to lutropin. The above results (table 1 B; fig. 1A,B) 
constitute direct evidence, lacking in [5], that 4-APP 
treatment does not seriously damage the luteal cellular 
mechanism for lutropin-dependent progesterone syn- 
thesis. This evidence thus validates the conclusion 
from table 1A that, when deprived of access to circu- 
lating lipoproteins, the corpus luteum loses much of 
its capacity for progesterone synthesis. The results in 
table 1A,B and fig.1 together constitute the first 
direct and conclusive vidence that the rat corpus 
luteum in vivo depends upon plasma lipoproteins 
for the maintenance of its steroidogenic function. 
The data given in table 1C demonstrate hat HDL is 
the specific lipoprotein upon which the corpus luteum 
depends, indicating an essential role for HDL in luteal 
progesterone synthesis in the rat. It should be noted 
that although LDL (d = 1.006-1.065) is a major 
component of human plasma, rat plasma contains 
hardly any material in this density band [10]. We 
have been able to obtain enough rat LDL for only 
a single experiment; his lipoprotein fraction had 
no effect on progesterone synthesis (not shown). 
There is at present no evidence to explain in molec- 
ular terms how HDL functions in luteal steroido- 
genesis but several observations suggest hat it would 
be premature to assume that the only possible role of 
HDL is to supply cholesterol as a substrate for proges- 
terone synthesis [1,5 ], especially in view of the report 
of how specific lipoproteins can modulate adenylate 
cyclase activity in cell membranes [11]. 
(i) 4-APP treatment lowers plasma lipoprotein levels 
but not cholesterol levels selectively; lipoproteins 
contain several components other than choleste- 
rol and its esters. 
(ii) The proposed [1,5] connection between plasma 
and tissue cholesteryl ester levels and luteal pro- 
gesterone synthesis is based upon an observed 
correlation rather than upon direct experimenta- 
tion. 
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Progesterone synthesis by isolated luteal cells 
Progesterone formed (ng. 104 cells -1 . 2 h -1) 
Cells from rats Cells from rats 
not treated with 4-APP treated with 4-APP 
A -  17.4-+ 7.2 (3) 3.0-+ 0.8 (3) 
Lutropin (100 ng/ml) 95.8 + 19.0 (3) 11.5 + 4.0 (3) 
B-  - 2.4-+ 0.8 (3 )  
Lutropin (100 ng/ml) - 11.9 -+ 4.1 (3) 
Plasma total ipoprotein (d < 1.225) - 18.4 -+ 4.2 (3) 
Lutropin (100 ng/ml) + plasma 
total ipoprotein (d < 1.225) 139.1 -+ 10.4 (3) 
C - 
Lutropin (100 ng/ml) - 9.2 -+ 1.9 (3) 
Lutropin + .VLDL (d < 1.006) - 13.8 +- 3.3 (3) 
Lutropin + HDL (d = 1.065-1.209) - 47.1 -+ 8.8 (3) 
Lutropin + plasma total ipoprotein 
(d < 1.225) - 41.6 +- 8.2 (3) 
Methods for superovulating the rats, treating them with 4-APP and isolating the luteal 
cells are in section 2. Cells were incubated for 2 h at 37°C and, when present, lipopro- 
tein fractions containing 1 mg protein were added to each incubation. Progesterone was 
extracted and assayed as in section 2. Values are means -+ SEM; no. obs. shown in paren- 
theses 
Measurements of the effect of 4-APP treatment on 
luteal content of cholesteryl ester were made using 
whole ovaries rather than cells isolated from these 
and used in measuring progesterone synthesis [5]. 
These isolated cells need not have been typical, in 
their cholesteryl ester content, of the whole organ 
from which they were derived. Measurements on our 
own isolated cells showed that 4-APP treatment low- 
ered luteal cell cholesteryl ester content from 20.0 + 
3.8(3)-4.7 + 0.8(3) tag/106 cells, but it should be 
noted that the quantity of cholesteryl ester in these 
cells still exceeded by ~1000-fold the amount of pro- 
gesterone which these cells could synthesize. Thus 
there was no direct quantitative relationship between 
cellular cholesteryl ester content and cellular capacity 
to synthesize progesterone. Furthermore, a time- 
course of progesterone synthesis, by cells isolated 
from 4-APP-treated rats incubated in the presence of 
plasma total l ipoprotein fraction, was qualitatively 
identical to that given by similar cells incubated with- 
out lipoproteins (not shown). There was no 'lag- 
period' which might have been expected if proges- 
terone synthesis had had to await the replenishing of 
cellular cholesteryl ester through uptake from external 
l ipoprotein. There was no significant difference in 
unesterified cholesterol content between luteal cells 
from rats not treated with 4-APP (5.2 -+ 2.4(3) tag/10 6
cells) and luteal cells from 4-APP-treated rats (5.8 -+ 
1.0(3) tag/10 6 cells). 
It would also be premature to suppose that a mech- 
anism analagous to the LDL-pathway [12], but utilis- 
ing HDL instead of LDL, is involved in luteal proges- 
terone synthesis. Although the component events of 
the LDL-pathway have been demonstrated in cultured 
mouse adrenal tumour cells [13], no direct evidence 
was presented to show that this LDL-pathway consti- 
tuted an essential part of the overall process of steroid 
synthesis by these cultured cells. Specific HDL recep- 
tors have been observed in rat testis cell membranes 
[ 14] but no evidence was given to link these receptors 
with the process of steroid production. Mechanisms 
for cell and lipoprotein interaction ot involving lipo- 
protein internalization are known to exist in steroid- 
ogenic tissues [15]. Clearly, comprehensive experi- 
mentation will be necessary to define the processes 
whereby the entire HDL complex interacts with the 
mechanism of progesterone synthesis in our corpus 
luteum cell preparation. Experiments which focus 
upon one HDL component alone, e.g., its sterol, or 
which simply measure the uptake and metabolism 
81 
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of HDL without attempting to relate these events to 
the mechanism of progesterone synthesis, will give 
only a preliminary and incomplete answer to the 
question of how HDL functions in luteal steroido- 
genesis. 
Acknowledgement 
This work was supported by a grant from the 
Medical Research Council. 
References 
[ 1] Andersen, J. M. and Dietschy, J. M. (1978) J. BioL 
Chem. 253, 9024-9032. 
[2] Henderson, J. F. (t963) J. Lipid Res. 4, 68-74. 
[3] Nichols, A. V., Gong, E. L. and Blanche, P. J. (1981) 
Biochem. Biophys. Res. Commun. 100, 391-399. 
[4] Van't Hooft, F. M., Van Gent, T. and Van Tol, A. 
(1981) Biochem. J. 196, 877-885. 
[5] Christie, M. H., Strauss, J. F. and Flickinger, G. L. 
(1979) Endocrinology 105, 92-98. 
[6] McNamara, B. C., Cranna, C. E. G., Booth, R. and 
Stansfield, D. A. (1980) Biochem. J. 192,559-567. 
[7] Rudel, L. L., Lee, J. A., Morris, M. D. and Felts, J. M. 
(1974) Biochem. J. 139, 89-95. 
[8] Koga, S., Horwitz, D. L. and Scanu, A. M. (1969) J. 
Lipid Res. 10, 577-588. 
[9] Baqir, Y. A. and Booth, R. (1977) Biochem. J. 164, 
501-508. 
[ t0] Mills, G. L. and Taylaur, C. E. (1971) Comp. Biochem. 
Physiol. 40, 489-501. 
[ 11 ] Ghiselli, G., Sirtori, C. R. and Nicosia, S. (1981) Bio- 
chem. J. 196,899-902. 
[ 12] Goldstein, J. L. and Brown, M. S. (1977) Annu. Rev. 
Biochem. 46, 897-930. 
[13] Faust, J. R., Goldstein, J. L. and Brown, M. S. (1977) J. 
Biol. Chem. 252, 4861-4871. 
[14] Chen, Y. I., Kraemer, F. B. and Reaven, G. M. (1980) 
J. Biol. Chem. 255, 9t62--9167. 
[15] Jansen, H. and DeGreef, W. J. (1981) Biochem. J. 196, 
739-745. 
82 
